S S Pierangeli - Concepedia

Author

S S Pierangeli

Also Known As

C. Pericleous, S PIERANGELI, S Pierangeli, S S Pierangeli, S. S. PIERANGELI, S. S. Pierangeli, S.S. PIERANGELI, S.S. Pierangeli, Silvia Pierangeli

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Louisville Morehouse School of Medicine The University of Texas Medical Branch at Galveston University of Milan

About

S S Pierangeli is an author at University of Louisville specializing in medicine, immunology, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	767
2	Allergy	4	4	154
3	Public Health	2	2	121
4	Health Sciences	1	1	11
5	Natural Sciences	1	1	18

S S Pierangeli

Publications

966

Citations

H-Index

Page 1

	Year	Citations
Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH Katrien Devreese, S S Pierangeli, Bas de Laat, Journal of Thrombosis and Haemostasis Solid Phase AssaysImmunohematologyImmunocytochemical TechniqueBioanalysisImmunology	2014	214
Functional Analyses of Patient-derived IgG Monoclonal Anticardiolipin Antibodies Using In Vivo Thrombosis and In Vivo Microcirculation Models S S Pierangeli, Xiaowei Liu, Ricardo Espinola, Thrombosis and Haemostasis ImmunologyCell DeathAntiphospholipid AntibodiesImmunotherapyInflammation	2000	100
A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus Carolyn B. Gleason, Marcus F. Stoddard, Stephen G. Wagner, American Heart Journal Heart FailureCardiovascular DiseaseLupusLupus NephritisCardiology	1993	98
A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice. T Olee, S S Pierangeli, Harold H. Handley, Proceedings of the National Academy of Sciences ImmunologyPathologyAntiphospholipid AntibodiesHyperlipidemiaThrombosis	1996	82
Role of p38 mitogen‐activated protein kinase in antiphospholipid antibody‐mediated thrombosis and endothelial cell activation Mariano E. Vega-Ostertag, Dardo E. Ferrara, Zurina Romay‐Penabad, Journal of Thrombosis and Haemostasis InflammationThrombosisSignal TransductionBlood PlateletImmunology	2007	79
Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells. Nicoletta Del Papa, Pier Luigi Meroni, Anǵela Tincani, PubMed Vascular DiseaseImmunologyBiomedical EngineeringImmune SystemImmunotherapy	1992	68
<i>In Vivo</i> Effects of an Inhibitor of Nuclear Factor‐Kappa B on Thrombogenic Properties of Antiphospholipid Antibodies Guadalupe Montiel-Manzano, Zurina Romay‐Penabad, Elizabeth Papalardo de Martinez, Annals of the New York Academy of Sciences	2007	67
Interactions and molecular structure of cardiolipin and β2-glycoprotein 1 (β2-GP1) Douglas Borchman, Edward N. Harris, S S Pierangeli, Clinical & Experimental Immunology	1995	46
Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases. Peter A. Merkel, Yuan‐Yen Chang, S S Pierangeli, PubMed	1999	46
Familial anticardiolipin antibodies and C4 deficiency genotypes that coexist with MHC DQB1 risk factors. W A Wilson, E Scopelitis, JP Michalski, PubMed	1995	40

Page 1